CD8(hi+)CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity

International Immunology

Volumn 10, Issue 3, 1998, Pages 311-323

  Mollet, Lucile ^a   Sadat Sowti, Béhazine ^a   Duntze, Jörg ^a   Leblond, Véronique ^a   Bergeron, Florence ^a   Calvez, Vincent ^a   Katlama, Christine ^a   Debré, Patrice ^a   Autran, Brigitte ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

AIDS HIV; CD8+CD57+ lymphocytes; Cytotoxic T lymphocytes; Immunomodulators; Transplantation

Indexed keywords

CD11B ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN P 15095; GRANZYME B; HLA DR ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MITOGENIC AGENT; PADGEM PROTEIN; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 6;

ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; T LYMPHOCYTE; VIRUS TITRATION; CELL DIFFERENTIATION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANTIGENS, CD57; ANTIGENS, CD8; CELL DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031596522     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.3.311     Document Type: Article

References (59)

1. + lymphocytes from AIDS patients inhibits T cell cytotoxicity. Eur. J. Immunol. 21:737.
2. + cells in AIDS, ARC and asymptomatic individuals. J. Clin. Immunol. 6:502.
3. +/HNK1 suppressor lymphocytes in the blood of long term surviving patients after allogeneic bonemarrow transplantation. J. Immunol. 137:2180.
4. + (Leu 7) and other lymphocyte subsets in long-term survivors with renal allotransplants. Transplantation 35:25.
5. + subset. Clin. Exp. Immunol. 62:515.
6. + cells that suppresses T cell proliferative responses. J. Immunol. 131:2757.
7. + cells that suppresses B cell differentiation. J Immunol. 133:2461.
8. Halwani, F., Guttman, R. D., Ste-Croix, H. and Prud'homme, G. J. 1992. Identification of natural suppressor cells in long-term renal allograft recipients. Transplantation 54:973.
9. Joly, P., Guillon, J. M., Mayaud, C., Plata, F., Théodorou, I., Denis, M., Debré, P. and Autran, B. 1989. Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J. Immunol. 143:2193.
10. Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraetere, V., Nagata, S., Hengartner, H. and Golstein, P. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 265:528.
11. Isaaz, S., Baetz, K., Olsen, K., Podack, E. and Griffiths, G. M. 1995. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 25:1071.
12. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425
13. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
14. Hemler, M. E. 1990. VLA proteins in the integrin family: structures, functions and their role on leukocytes. Annu. Rev. Immunol. 8:365.
15. + T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells. J. Immunol. 151:429.
16. Kägi, D., Seiler, P., Pavlovic, J., Ledermann, B., Bürki, K., Zinkernagel, R. M. and Hengartner, H. 1996. The roles of perforinand Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J Immunol. 25:3256.
17. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271:173.
18. Akbar, A. N., Borthwick, N., Salmon, M., Gombert, W., Bofill, M., Shamsadeen, N., Pilling, D., Pett, S., Grundy, J. E. and Janossy, G. 1993. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J. Exp. Med. 178:427
19. Sloan-Lancaster, J., Evavold, B. D. and Allen, P. M. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
20. Mingari, M. C., Vitale. C., Cambiaggi, A., Schiavetti, F., Melioli, G., Ferrini, S. and Poggi, A. 1995. Cytotoxic T lymphocytes displaying natural killer (NK)-like activity: expression of NK related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCP-mediated target cell lysis or lymphokine production. Int. Immunol. 7:697.
21. + T helper type 2 cells. J. Exp. Med. 181:5.
22. + T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients. Eur. J. Immunol. 24:2882.
23. Abo, T. and Balch, C. M. 1981. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol. 127:1024.
24. Giorgi, J. V. and Detels, R. 1989. T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study. Clin. Immunol. Immunopathol. 52:10.
25. Salazar-Gonzalez, J. F., Moody, D. J., Giorgi, J. V., Martinez-Maza, R., Mitsuyasu, R. T. and Fahey,J. L. 1985. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T-suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity. J. Immunol. 135:1778.
26. + cytotoxic T cells express CD38 and HLA-DR antigens. J. Immunol. 150:3070.
27. + T lymphocytes during HIV-1 infection. J. Acquir. Immune Defic. Syndr. 7: 245.
28. Würsch, A. M., Gratama, J. W., Middeldorp, J. M., Nissen, C., Gratwohl, A., Speck, B., Jansen, J., D'Amaro, J., The, T. H, and De Gast, G. C. 1985. The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin. Exp. Immunol. 62:278.
29. + T lymphocytes from bone marrow allografted patients mediate a soluble suppressor activity on allospecific, lymphokin-activited and natural cytolytic functions. Blood 77:2237.
30. - precursors by differentiation occuring in late immune responses. Eur. J. Immunol. 24:1503.
31. + T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection Blood 79:1746.
32. - T helper cells with a THO-TH2 function in kidney transplant recipient. Transplant. Proc. 27:1676.
33. - T lymphocyte subset in normal and HIV-seropositive individuals. J. Immunol. 154:1408.
34. Lanier, L. L. and Loken, M. R. 1984. Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis. J. Immunol. 132:151.
35. Rüthlein, J., James S. P. and Strober, W. 1988. Role of CD2 in activation and cytotoxic function of CD8/Leu 7 positive T cells J. Immunol. 141:3791.
36. Phillips, J. H. and Lanier, L. L. 1986. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. J. Immunol. 136:1579.
37. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J. Immunol. 155:5047.
38. + cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin. Exp. Immunol. 94:297.
39. Lombardi, G., Sidhu, S., Batchelor, R. and Lechler, L. 1994. Anergic T cells as suppressor cells in vitro. Science. 264:1587.
40. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Natl Acad. Sci. USA 88:11276
41. Levacher, M., Hulstaert, F., Tallet, S., Ullery, S., Pocidalo, J. J. and Bach, B. A. 1992. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin. Exp. Immunol. 90: 376.
42. + T cell homeostasis and function in advanced HIV disease. Science 277:112
43. Bell, E. B, and Sparshott, S. M. 1990. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 348:163.
44. Shimizu, Y., Newman, W., Tanaka, Y. and Shaw, S. 1992. Lymphocyte interactions with endothelial cells. Immunol. Today 13:106.
45. Kansas, G. S. 1996. Selectins and their ligands: current concept and controversies. Blood 88:3259
46. Rabin, R. L., Roederer, M., Maldonado, Y., Petru, A., Herzenberg, L. A. and Herzenberg, L. A. 1995. Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. J. Clin. Invest. 95: 2054
47. Shimizu, Y., Van Seventer, G., Horgan, K. J. and Shaw, S. 1990. Regulated expression and binding of three VLA (β1), integrin receptors on T cells. Nature 345:250.
48. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11.
49. Chadburn, A., Inghirami, G. and Knowles, D. M. 1993. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells. Hematol. Pathol. 6:193
50. + T cells is induced by some combinations of anti-CD2 mAb. J. Immunol. 151:3547.
51. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370:463.
52. Azuma, M., Phillips, J. H. and Lanier, L. L. 1993. CD28- T lymphocytes. Antigenic and functional properties. J. Immunol. 150:1147.
53. + T cells from HIV-infected subjects. Clin. Exp. Immunol. 100:425.
54. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 10:F17.
55. + T cell turnover. Science 274:1543
56. Viola, A. and Lanzavecchia, A. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
57. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. A., McHeyzer-Williams, M. G., Bell, J. I., McMickael, A. J. and Davis, M. M. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94
58. + T cells with restricted T-cell receptor β chain variability after bone marrow transplantation. Blood 83:587.
59. Jassoy, C., Harrer, T., Rosenthal, T., Navia, B. A., Worth, J., Johnson, R. P. and Walker, B. D. 1993. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma Interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens. J. Virol. 67:2844